已收录 268921 条政策
 政策提纲
  • 暂无提纲
Novel 4-aminoquinoline analogues as antimalarial agents: A review
[摘要] Malaria remains the worlds’ most devastating human parasitic infection, afflicting 500 million people and causing from 1.7-2.5 million deaths each year globally. 4-aminoquinoline drugs are highly effective and rapidly acting agents against asexual erythrocytic stages of malaria parasites mainly P. vivax and P. falciparum responsible for life threatening clinical manifestations and severity of the disease. However, development of resistance of malaria parasites, especially P. falciparum towards CQ (the most potent and less toxic 4-aminoquinoline drug) has limited its use in the treatment of malaria. The present review article depicted the antimalarial activity of novel series of 4-aminoquinoline structural analogues against different CQ-sensitive as well as CQresistant strains of Plasmodium species especially P. falciparum.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文